Effect of buprenorphine on the treatment of psychosis in bipolar patients with psychotic symptoms
Phase 3
Recruiting
- Conditions
- Psychosis.Other stimulant related disorders
- Registration Number
- IRCT20190905044703N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 18 to 65
Diagnosis of type 1 BMD (Depression episode, Mania with Psychotic Leader) (based on DSM-V criteria)
Initial Severity of Positive Symptoms: BPRS psychotic score with a score of 12 or greater and at least two BPRS psychotic items with a score of 4 or more
Exclusion Criteria
A history of methamphetamine use within the last 3 months
Alcohol dependence or benzodiazepines or hallucinogenic substances
Diagnosis of methamphetamine-induced sustained psychosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Psychosis leaderboard. Timepoint: The first day before the intervention and the fourth day after the intervention. Method of measurement: interview.
- Secondary Outcome Measures
Name Time Method